Literature DB >> 998246

The diagnosis of cancer from body fluids. A comparison of cytology, DNA measurement, tissue culture, scanning and transmission microscopy.

H Krivinkova, J Pontén, T Blöndal.   

Abstract

A consecutive series of 70 exudates from 45 patients with clinically suspected malignancy was examined by cytology, cytophotometric measurement of DNA, short-term cell culture, scanning and transmission electron microscopy. In seven patients (21 fluids), the presence of malignant disease was verified. Malignant and benign cases were correctly diagnosed by combination of cytology and DNA analyses. An abnormal DNA profile defined by greater than 10 per cent cells with greater than 2c DNA or single cells with greater than 8c DNA was only seen in malignant exudates. Short-term cell culture with scanning electron microscopy could distinguish between lymphoid cells, histiocytes, fibroblasts, mesothelial cells and cancer cells. Only cancer cells had prominent microvilli on their surface. A future larger series will explore whether a combination of cytology and cytophotometric DNA estimation alone will improve the diagnostic accuracy to the same substantial degree as this pilot study would suggest.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998246

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  3 in total

1.  Impact of positive intraabdominal lavage cytology on the long-term prognosis of colorectal cancer patients.

Authors:  Rita Temesi; László Sikorszki; János Bezsilla; Akos Botos; Judit Kovács; Tibor Tihanyi
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

2.  Polyploidy in non-neoplastic tissues.

Authors:  S Biesterfeld; K Gerres; G Fischer-Wein; A Böcking
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

3.  Scanning electron microscopy of malignant gliomas. A comparative study of glioma cells in smear preparations and in tissue culture.

Authors:  R González-Cámpora; L W Haynes; R O Weller
Journal:  Acta Neuropathol       Date:  1978-03-15       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.